Navinci Appoints Magnus Hurst as New Chief Financial Officer
Navinci is pleased to announce the appointment of Magnus Hurst as its Chief Financial Officer (CFO), marking the next phase of growth for the company.
Introducing Naveni® Plex
Navinci is proud to introduce Naveni® Plex, the first multiplex in situ proximity ligation assay, allowing for the simultaneous detection of three separate targets or protein-protein interactions.
New kits for Leica BOND RX/RXm with fluorescent readout
Leica Biosystems and Navinci collaborate to automate in situ proximity ligation assays, now with fluorescent readout.
Jenny Sundqvist appointed CEO of Navinci
Navinci’s Board of Directors is pleased to announce the appointment of Jenny Sundqvist as the new Chief Executive Officer, effective December 1, 2024.
Precision for Medicine and Navinci Announce Strategic Partnership
A partnership announced between Precision for Medicine and Navinci to offer isPLA as part of Precision for Medicine’s CRO services.
Partnership announced between Canopy Biosciences and Navinci
A partnership announced between Canopy Biosciences and Navinci to offer isPLA as part of Canopy’s CRO services.
Navinci Housewarming Party
Last Friday (May 3), Navinci had the absolute pleasure of hosting a housewarming party to celebrate the grand opening of our new office, with a fantastic turnout.
Navinci expands into new facilities
Navinci celebrates a milestone, relocating to Uppsala Science Park, bolstering R&D capabilities. The move reflects continued growth and commitment to pioneering spatial proteomics.
Navinci and 2BScientific announce a strategic partnership
Navinci partners with 2BScientific, UK’s premier life sciences distributor, expanding reach for spatial proteomics assays, benefiting researchers with innovative solutions in the UK.
Navinci joins Milner Therapeutics Institute Affiliated Company scheme
Navinci joins the Milner Therapeutics Institute Affiliated Company scheme, fostering collaboration among academic, pharmaceutical, and biotech partners to advance research and innovation.
Navinci and Vector Labs announce strategic collaboration
Vector Laboratories and Navinci Diagnostics partner to pioneer biomarker discovery tools, enabling specific protein glycosylation detection in tissue samples, revolutionizing glycoproteomic research.